SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001144204-13-040868
Filing Date
2013-07-24
Accepted
2013-07-24 13:42:51
Documents
1
Group Members
ALAIN L. AZANDR. JAMES I. HEALYDR. MICHAEL F. POWELLERIC P. BUATOISSOFINNOVA MANAGEMENT VI, L.L.CSOFINNOVA VENTURE AFFILIATES VI, L.PSOFINNOVA VENTURE PARTNERS VI GMBH & CO. KG

Document Format Files

Seq Description Document Type Size
1 FORM SC 13D v350709_sc13d.htm SC 13D 156459
  Complete submission text file 0001144204-13-040868.txt   158378
Mailing Address 2800 SAND HILL ROAD SUITE 150 MENLO PARK CA 94025
Business Address 2800 SAND HILL ROAD SUITE 150 MENLO PARK CA 94025 650-681-8420
SOFINNOVA VENTURE PARTNERS VI L P (Filed by) CIK: 0001211465 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D

Mailing Address 12651 HIGH BLUFF DRIVE SUITE 230 SAN DIEGO CA 92130
Business Address 12651 HIGH BLUFF DRIVE SUITE 230 SAN DIEGO CA 92130 858-436-3900
Ocera Therapeutics, Inc. (Subject) CIK: 0001274644 (see all company filings)

IRS No.: 631192270 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-86177 | Film No.: 13983319
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences